Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies
INGELHEIM, Germany & SAN FRANCISCO--(BUSINESS WIRE)--Boehringer Ingelheim and 3T Biosciences, today announced they have entered into a strategic collaboration and licensing agreement to dis......

